Fischer Sarah, Neurath Markus F
Medizinische Klinik 1, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Deutschland.
Deutsches Zentrum Immuntherapie (DZI), Erlangen, Deutschland.
Inn Med (Heidelb). 2025 Feb;66(2):137-145. doi: 10.1007/s00108-024-01838-5. Epub 2025 Jan 20.
The pathophysiology of inflammatory bowel diseases is not fully understood. In a staged model by the European Crohn's and Colitis Organization (ECCO) regarding disease development, it is assumed that there is a population at risk for manifestation of disease following subtle changes over time.
This work aims to summarize the current state of knowledge regarding the pathophysiology, prediction and prevention of chronic inflammatory bowel diseases.
Selective literature research via PubMed.
Several genetic, biochemical, and microbiome scores have the potential to identify individuals at increased risk of developing inflammatory bowel disease, possibly up to a decade before onset.
The growing knowledge regarding the pathogenesis of inflammatory bowel diseases makes prediction before disease onset a possible future diagnostic goal. Hypothetically, early changes before the disease manifests could be reversible and may be amenable to prevention programs.
炎症性肠病的病理生理学尚未完全明确。在欧洲克罗恩病和结肠炎组织(ECCO)的疾病发展分期模型中,假定存在这样一群人,随着时间的细微变化,他们有发病的风险。
这项工作旨在总结关于慢性炎症性肠病的病理生理学、预测和预防的当前知识状态。
通过PubMed进行选择性文献研究。
几种遗传、生化和微生物组评分有潜力识别出患炎症性肠病风险增加的个体,可能在发病前十年就可做到。
关于炎症性肠病发病机制的知识不断增加,使得疾病发作前的预测成为未来一个可能的诊断目标。假设在疾病显现之前的早期变化可能是可逆的,并且可能适用于预防方案。